MYRIAD GENETICS, INC. Increase (Decrease) in Accrued Interest Receivable, Net
MYRIAD GENETICS, INC. (MYGN) reported Increase (Decrease) in Accrued Interest Receivable, Net of $3.30 million for the 12-month period ending 2014-06-30, per its 10-K filed 2016-08-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2016-08-10
- MYRIAD GENETICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2014-06-30 was -$37.00K, a 105.29% decline year-over-year.
- MYRIAD GENETICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2014-03-31 was $2.00M, a 200.45% increase year-over-year.
- MYRIAD GENETICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2013-12-31 was $667.00K, a 0.15% increase year-over-year.
- MYRIAD GENETICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2013-09-30 was $666.00K, a 0.15% decline year-over-year.
- MYRIAD GENETICS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2014 was $3.30M, a 22.22% increase from fiscal 2013.
- MYRIAD GENETICS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2013 was $2.70M, a 35.00% increase from fiscal 2012.
- MYRIAD GENETICS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2012 was $2.00M.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month | Increase (Decrease) in Accrued Interest Receivable, Net 9 month | Increase (Decrease) in Accrued Interest Receivable, Net 12 month | Increase (Decrease) in Accrued Interest Receivable, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2014-06-30 | -$37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-10 | $1.97M derived: sum of 2 quarters · filed 2016-08-10 | $2.63M derived: sum of 3 quarters · filed 2016-08-10 | $3.30M 10-K · filed 2016-08-10 | $3.34M 10-K · filed 2014-08-13 |
| 2014-03-31 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | $2.67M derived: sum of 2 quarters · filed 2015-05-06 | $3.34M 10-Q · filed 2015-05-06 | $4.04M derived: sum of 4 quarters · filed 2015-08-12 | |
| 2013-12-31 | $667.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-04 | $1.33M 10-Q · filed 2015-02-04 | $2.03M derived: sum of 3 quarters · filed 2015-08-12 | $2.70M derived: sum of 4 quarters · filed 2015-08-12 | |
| 2013-09-30 | $666.00K 10-Q · filed 2014-11-05 | $1.37M derived: sum of 2 quarters · filed 2015-08-12 | $2.03M derived: sum of 3 quarters · filed 2015-08-12 | $2.70M derived: sum of 4 quarters · filed 2015-08-12 | |
| 2013-06-30 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-12 | $1.37M derived: sum of 2 quarters · filed 2015-08-12 | $2.03M derived: sum of 3 quarters · filed 2015-08-12 | $2.70M 10-K · filed 2015-08-12 | $2.67M 10-K · filed 2013-08-14 |
| 2013-03-31 | $667.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | $1.33M derived: sum of 2 quarters · filed 2014-05-07 | $2.00M 10-Q · filed 2014-05-07 | $2.67M derived: sum of 4 quarters · filed 2014-08-13 | |
| 2012-12-31 | $666.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-05 | $1.33M 10-Q · filed 2014-02-05 | $2.00M derived: sum of 3 quarters · filed 2014-08-13 | $2.67M derived: sum of 4 quarters · filed 2014-08-13 | |
| 2012-09-30 | $667.00K 10-Q · filed 2013-11-12 | $1.33M derived: sum of 2 quarters · filed 2014-08-13 | $2.00M derived: sum of 3 quarters · filed 2014-08-13 | ||
| 2012-06-30 | $667.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | $1.33M derived: sum of 2 quarters · filed 2014-08-13 | $2.00M 10-K · filed 2014-08-13 | ||
| 2012-03-31 | $666.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | $1.33M 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | $667.00K 10-Q · filed 2013-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |